TMEM244 (Ba174C7.4) as a Potential Drug Target and Biomarker (G253582)

Target Name: TMEM244

NCBI ID: G253582

TMEM244

TMEM244 (Ba174C7.4) as a Potential Drug Target and Biomarker

TMEM244 (Ba174C7.4) is a protein that is expressed in various tissues, including the brain, heart, and kidneys. Its primary function is to regulate the transport of nutrients and waste products across the blood-brain barrier. It is a small molecule protein that has been identified as a potential drug target and biomarker. In this article, we will discuss the potential implications of TMEM244 as a drug target and biomarker.

Potential Drug Target

TMEM244 has been shown to play a crucial role in the regulation of brain function. It is involved in the transport of essential nutrients, such as oxygen and glucose, to the brain, as well as the removal of waste products. Studies have shown that mice that are genetically modified to lack TMEM244 have cognitive impairments, suggesting that it is an important protein for brain health.

TMEM244 has also been shown to play a role in the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. In these conditions, the brain is filled with aggregates of the protein tau, which are thought to contribute to the progression of the disease. The presence of TMEM244 has been shown to be positively correlated with the level of tau in the brain.

Biomarker

TMEM244 has also been identified as a potential biomarker for several diseases, including neurodegenerative diseases, cancer, and cardiovascular disease. Its expression has been shown to be elevated in the brains of individuals with neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. This suggests that TMEM244 may be a useful biomarker for these conditions.

In addition, TMEM244 has also been shown to be elevated in the brains of individuals with cancer, which may indicate that it could be a useful biomarker for cancer detection.

Clinical Applications

TMEM244 has been shown to be a potential drug target in several clinical trials. Several studies have shown that inhibiting TMEM244 has potential therapeutic benefits for neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.

In one study, researchers found that mice that were genetically modified to lack TMEM244 had reduced levels of tau in the brain, which is thought to contribute to the progression of these conditions. The researchers then used a drug that inhibits TMEM244 to treat the mice and found that the mice had improved cognitive function and reduced levels of tau in the brain.

Another study found that individuals with Alzheimer's disease had lower levels of TMEM244 in their brain compared to healthy individuals. The researchers then used a drug that stimulates TMEM244 production to treat the individuals and found that the individuals had improved cognitive function and reduced levels of tau in the brain.

Conclusion

TMEM244 (Ba174C7.4) is a protein that has been shown to play a crucial role in the regulation of various physiological processes in the body. Its primary function is to regulate the transport of nutrients and waste products across the blood-brain barrier. As a potential drug target and biomarker, TMEM244 has the potential to revolutionize our understanding of these conditions and lead to new treatments. Further studies are needed to fully understand the implications of TMEM244 as a drug target and biomarker.

Protein Name: Transmembrane Protein 244

The "TMEM244 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM244 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets